img

Targeted Drugs for Breast Cancer Industry: Global Market Opportunities and Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 432 | Industry : Medical Care

Publisher : MRG | Format : PDF

Targeted Drugs for Breast Cancer Industry: Global Market Opportunities and Forecast 2024-2034

This report provides a comprehensive analysis of current global Targeted Drugs for Breast Cancer market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Targeted Drugs for Breast Cancer industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Targeted Drugs for Breast Cancer market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Targeted Drugs for Breast Cancer Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Targeted Drugs for Breast Cancer market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Targeted Drugs for Breast Cancer Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Targeted Drugs for Breast Cancer industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
HER-2 Targeted Drugs
CDK4/6 Inhibitors
PARP Targeted Drugs
PI3K/AKT/mTor Pathway Inhibitors
ER Targeted Drugs
Aromatase Inhibitors
Tubulin Inhibitors
VEGF Targeted Drugs
YTMS Targeted Drugs

Segmented by Application
Hospital
Clinic
Drug Center
Other

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Teva
Roche
Reliance Group
Puma Biotechnology
Pfizer
Otsuka Pharmaceutical
Novartis
Mylan
Merck
Hikma
Hetero
Hengrui Pharmaceutical
Hengrui Medicine
GlaxoSmithKline
Eli Lilly
Eisai
Cipla
Chugai Pharmaceutical
CANbridge
Bristol-Myers Squibb
BioMarin
Beijing Biostar Technologies
Bayer
AstraZeneca


Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Targeted Drugs for Breast Cancer Market Status and Forecast (2016-2027)
1.3.2 Global Targeted Drugs for Breast Cancer Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Targeted Drugs for Breast Cancer Supply by Company
2.1 Global Targeted Drugs for Breast Cancer Sales Value by Company
2.2 Targeted Drugs for Breast Cancer Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Targeted Drugs for Breast Cancer Market Status by Type
3.1 Targeted Drugs for Breast Cancer Type Introduction
3.1.1 HER-2 Targeted Drugs
3.1.2 CDK4/6 Inhibitors
3.1.3 PARP Targeted Drugs
3.1.4 PI3K/AKT/mTor Pathway Inhibitors
3.1.5 ER Targeted Drugs
3.1.6 Aromatase Inhibitors
3.1.7 Tubulin Inhibitors
3.1.8 VEGF Targeted Drugs
3.1.9 YTMS Targeted Drugs
3.1.10 Other
3.2 Global Targeted Drugs for Breast Cancer Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Targeted Drugs for Breast Cancer Market Status by Application
4.1 Targeted Drugs for Breast Cancer Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Drug Center
4.1.4 Other
4.2 Global Targeted Drugs for Breast Cancer Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Targeted Drugs for Breast Cancer Market Status by Region
5.1 Global Targeted Drugs for Breast Cancer Market by Region
5.2 North America Targeted Drugs for Breast Cancer Market Status
5.3 Europe Targeted Drugs for Breast Cancer Market Status
5.4 Asia Pacific Targeted Drugs for Breast Cancer Market Status
5.5 Central & South America Targeted Drugs for Breast Cancer Market Status
5.6 Middle East & Africa Targeted Drugs for Breast Cancer Market Status
6 North America Targeted Drugs for Breast Cancer Market Status
6.1 North America Targeted Drugs for Breast Cancer Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Targeted Drugs for Breast Cancer Market Status
7.1 Europe Targeted Drugs for Breast Cancer Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Targeted Drugs for Breast Cancer Market Status
8.1 Asia Pacific Targeted Drugs for Breast Cancer Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Targeted Drugs for Breast Cancer Market Status
9.1 Central & South America Targeted Drugs for Breast Cancer Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Targeted Drugs for Breast Cancer Market Status
10.1 Middle East & Africa Targeted Drugs for Breast Cancer Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Targeted Drugs for Breast Cancer Market Forecast by Type and by Application
12.1 Global Targeted Drugs for Breast Cancer Sales Value Forecast (2022-2027)
12.2 Global Targeted Drugs for Breast Cancer Forecast by Type
12.3 Global Targeted Drugs for Breast Cancer Forecast by Application
13 Global Targeted Drugs for Breast Cancer Market Forecast by Region/Country
13.1 Global Targeted Drugs for Breast Cancer Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Teva
14.1.1 Company Information
14.1.2 Targeted Drugs for Breast Cancer Product Introduction
14.1.3 Teva Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Roche
14.2.1 Company Information
14.2.2 Targeted Drugs for Breast Cancer Product Introduction
14.2.3 Roche Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Reliance Group
14.3.1 Company Information
14.3.2 Targeted Drugs for Breast Cancer Product Introduction
14.3.3 Reliance Group Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Puma Biotechnology
14.4.1 Company Information
14.4.2 Targeted Drugs for Breast Cancer Product Introduction
14.4.3 Puma Biotechnology Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Pfizer
14.5.1 Company Information
14.5.2 Targeted Drugs for Breast Cancer Product Introduction
14.5.3 Pfizer Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Otsuka Pharmaceutical
14.6.1 Company Information
14.6.2 Targeted Drugs for Breast Cancer Product Introduction
14.6.3 Otsuka Pharmaceutical Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Novartis
14.7.1 Company Information
14.7.2 Targeted Drugs for Breast Cancer Product Introduction
14.7.3 Novartis Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Mylan
14.8.1 Company Information
14.8.2 Targeted Drugs for Breast Cancer Product Introduction
14.8.3 Mylan Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Merck
14.9.1 Company Information
14.9.2 Targeted Drugs for Breast Cancer Product Introduction
14.9.3 Merck Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 Hikma
14.10.1 Company Information
14.10.2 Targeted Drugs for Breast Cancer Product Introduction
14.10.3 Hikma Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 Hetero
14.12 Hengrui Pharmaceutical
14.13 Hengrui Medicine
14.14 GlaxoSmithKline
14.15 Eli Lilly
14.16 Eisai
14.17 Cipla
14.18 Chugai Pharmaceutical
14.19 CANbridge
14.20 Bristol-Myers Squibb
14.21 BioMarin
14.22 Beijing Biostar Technologies
14.23 Bayer
14.24 AstraZeneca
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Targeted Drugs for Breast Cancer Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Targeted Drugs for Breast Cancer Sales Value (Million USD) by Company (2019-2021)
Table Global Targeted Drugs for Breast Cancer Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Targeted Drugs for Breast Cancer Sales Area
Table Targeted Drugs for Breast Cancer Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Targeted Drugs for Breast Cancer Sales Value (Million USD) by Type (2016-2021)
Table Global Targeted Drugs for Breast Cancer Sals Value Market Share by Type (2016-2021)
Table North America Targeted Drugs for Breast Cancer Sales Value (Million USD) by Type (2016-2021)
Table North America Targeted Drugs for Breast Cancer Sales Value Market Share by Type (2016-2021)
Table Europe Targeted Drugs for Breast Cancer Sales Value (Million USD) by Type (2016-2021)
Table Europe Targeted Drugs for Breast Cancer Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Targeted Drugs for Breast Cancer Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Targeted Drugs for Breast Cancer Sales Value Market Share by Type (2016-2021)
Table Central & South America Targeted Drugs for Breast Cancer Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Targeted Drugs for Breast Cancer Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Targeted Drugs for Breast Cancer Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Targeted Drugs for Breast Cancer Sales Value Market Share by Type (2016-2021)
Table Global Targeted Drugs for Breast Cancer Sales Value (Million USD) by Application (2016-2021)
Table Global Targeted Drugs for Breast Cancer Value Market Share by Application (2016-2021)
Table North America Targeted Drugs for Breast Cancer Sales Value (Million USD) by Application (2016-2021)
Table North America Targeted Drugs for Breast Cancer Sales Value Market Share by Application (2016-2021)
Table Europe Targeted Drugs for Breast Cancer Sales Value (Million USD) by Application (2016-2021)
Table Europe Targeted Drugs for Breast Cancer Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Targeted Drugs for Breast Cancer Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Targeted Drugs for Breast Cancer Sales Value Market Share by Application (2016-2021)
Table Central & South America Targeted Drugs for Breast Cancer Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Targeted Drugs for Breast Cancer Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Targeted Drugs for Breast Cancer Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Targeted Drugs for Breast Cancer Sales Value Market Share by Application (2016-2021)
Table Global Targeted Drugs for Breast Cancer Sales Value (Million USD) by Region (2016-2021)
Table Global Targeted Drugs for Breast Cancer Value Market Share by Region (2016-2021)
Table North America Targeted Drugs for Breast Cancer Sales Value (Million USD) by Country (2016-2021)
Table North America Targeted Drugs for Breast Cancer Value Market Share by Country (2016-2021)
Table Europe Targeted Drugs for Breast Cancer Sales Value (Million USD) by Country (2016-2021)
Table Europe Targeted Drugs for Breast Cancer Value Market Share by Country (2016-2021)
Table Asia Pacific Targeted Drugs for Breast Cancer Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Targeted Drugs for Breast Cancer Value Market Share by Country (2016-2021)
Table Central & South America Targeted Drugs for Breast Cancer Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Targeted Drugs for Breast Cancer Value Market Share by Country (2016-2021)
Table Middle East & Africa Targeted Drugs for Breast Cancer Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Targeted Drugs for Breast Cancer Value Market Share by Country (2016-2021)
Table Global Targeted Drugs for Breast Cancer Value (Million USD) Forecast by Type (2022-2027)
Table Global Targeted Drugs for Breast Cancer Value Market Share Forecast by Type (2022-2027)
Table Global Targeted Drugs for Breast Cancer Value (Million USD) Forecast by Application (2022-2027)
Table Global Targeted Drugs for Breast Cancer Value Market Share Forecast by Application (2022-2027)
Table Global Targeted Drugs for Breast Cancer Value (Million USD) Forecast by Region (2022-2027)
Table Global Targeted Drugs for Breast Cancer Value Market Share Forecast by Region (2022-2027)
Table Teva Company Information
Table Teva Product Introduction
Table Teva Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Roche Company Information
Table Roche Product Introduction
Table Roche Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Reliance Group Company Information
Table Reliance Group Product Introduction
Table Reliance Group Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Puma Biotechnology Company Information
Table Puma Biotechnology Product Introduction
Table Puma Biotechnology Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Pfizer Company Information
Table Pfizer Product Introduction
Table Pfizer Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Otsuka Pharmaceutical Company Information
Table Otsuka Pharmaceutical Product Introduction
Table Otsuka Pharmaceutical Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Novartis Company Information
Table Novartis Product Introduction
Table Novartis Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Mylan Company Information
Table Mylan Product Introduction
Table Mylan Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Merck Company Information
Table Merck Product Introduction
Table Merck Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Hikma Company Information
Table Hikma Product Introduction
Table Hikma Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)